XIFAXAN® (rifaximin) For Adults with Overt HE and IBS-D
XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy recurrence and for the treatment of IBS-D in adults. See Important Safety Information and full Prescribing Information on website.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 302.446 |
| 2025-03 | 290.149 |
| 2025-04 | 247.066 |
| 2025-05 | 263.889 |
| Source | Traffic Share |
|---|---|
| search | 60.31% |
| direct | 15.30% |
| paid referrals | 15.01% |
| referrals | 8.32% |
| social | 1.03% |
| 0.03% |
| Region | Percentage |
|---|---|
| United States | 97.57% |
| Canada | 1.40% |
| India | 1.04% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| xifaxan | 4,624 | 46,240 | $2.97 |
| rifaximin | 7,571 | 75,710 | $3.70 |
| irritable bowel symptoms | 88 | 880 | $0.62 |
| xifaxan uses | 70 | 700 | $10.82 |
| blood in my stool but no pain | 36 | 360 | $0.00 |